GENEO Mezzanine invests in MyVariations to support the growth of its innovative oral health product range and facilitate expansion into European markets.
Information on the Target
MyVariations, founded in 2020 by Alexis and Martin Thiebaut, is a French brand dedicated to oral health. The company specializes in designing and marketing a comprehensive range of oral hygiene products, including sonic electric toothbrushes, all-natural toothpaste, dental floss, and various accessories. MyVariations has rapidly established itself as a credible alternative to traditional market leaders by focusing on user needs and innovative product development.
With a selective distribution strategy that emphasizes e-commerce and pharmacies, MyVariations has secured distribution in over 5,000 pharmacies and achieved impressive sales of nearly €35 million. The company's goal is to strengthen its presence in France by enhancing pharmacy distribution while also expanding its reach into multiple European countries, particularly Spain and Italy. This ambitious growth strategy is anchored in maintaining existing sales channels, diversifying the product range, and continuously innovating in collaboration with health professionals.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The oral health products industry in France is experiencing significant growth driven by increasing consumer awareness of dental hygiene and a shift towards natural and sustainable products. The market is witnessing a s
Similar Deals
Cerea Partners → Vincent Guerlais
2025
FrenchFood Capital and Cerea Partners → Boulangeries Sophie Lebreuilly
2025
GENEO Mezzanine
invested in
MyVariations
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Revenue: $35M